Sort
64,565 grants matching “drug discovery”
Center for Applied Preclinical Research (CAPR)
$1,817,445Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Small molecule mimetics of Humanin that normalize neuronal p-Akt as novel therapeutics for AD
$1,817,118Varghese John · University Of California Los Angeles · RF1 · FY2021 · AG
Emory/Atlanta Center for AIDS Research
$1,816,749James W. Curran · Emory University · P30 · FY2010 · AI
Bacteria and Host in TB Transmission
$1,816,206David Alland · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Viral Infection Influence on Transplantation Tolerance
$1,815,308Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AI
Disease mechanism and therapies for retinal degeneration
$1,815,101Tiansen Li · National Eye Institute · ZIA · FY2021 · EY
NCI-Frederick Support and Technical Services
$1,814,908Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2014 · CA
PD iPS Cell Line Research Consortium
$1,814,581Ole Isacson · Mclean Hospital · RC2 · FY2010 · NS
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
$1,813,624Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
Genetic variant-based drug discovery targeting conserved pathways of aging
$1,812,656Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2021 · AG
Genetic variant-based drug discovery targeting conserved pathways of aging
$1,812,559Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2019 · AG
Roles and regulation of p53
$1,812,196Carol Prives · Columbia Univ New York Morningside · P01 · FY2011 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,811,747Joe W. Gray · Oregon Health & Science University · U2C · FY2018 · CA
Developing Novel Antibiotics Against Yersinia pestis
$1,811,326Losee Lucy Ling · Novobiotic Pharmaceuticals, Llc · R44 · FY2007 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,811,310Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Collaborative Research: Frameworks: Interoperable High-Performance Classical, Machine Learning and Quantum Free Energy Methods in AMBER
$1,811,050Kenneth M Merz · Cleveland Clinic Foundation · · FY2024 · CSE
Countermeasures Against Chemical Threats ^ Preclinical Development Facility
$1,810,576Carol E Green · Sri International · N01 · FY2010 · NS
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$1,809,984Jin Wang · Baylor College Of Medicine · U01 · FY2020 · AG
Oncogenic Kinases in Cancer
$1,809,446John Brognard · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Chemical Countermeasures Collaboration: Chemical Threats Affecting the Respiratory/Pulmonary System
$1,809,217Office Of The Director, National Institutes Of Health · Y01 · FY2023 · OD
Viral Infection Influence on Transplantation Tolerance
$1,808,769Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Solomon H Snyder · Johns Hopkins University · P50 · FY2019 · DA
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Valina L. Dawson · Johns Hopkins University · P50 · FY2021 · DA
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Solomon H Snyder · Johns Hopkins University · P50 · FY2020 · DA
Targeting cell signaling pathways to disrupt drug abuse
$1,808,602Valina L. Dawson · Johns Hopkins University · P50 · FY2022 · DA